New Jersey Real Estate Attorney Christine Matus Explains Quitclaim Deeds and Divorce in New Jersey

New Jersey Real Estate Attorney Christine Matus Explains Quitclaim Deeds and Divorce in New Jersey

TOMS RIVER, NJ – November 10, 2026 — Dividing property is one of the most challenging aspects of divorce, and many couples in New Jersey rely on a quitclaim deed

Read More

Shopr Rewards Data Finds 98.2% of Converting Merchant Views Lead to Purchase Within Seven Days

New behavioral analysis released shows detailed purchaser intent. Orlando, Fla. – November 10, 2026 – Shopr Rewards, LLC, a fintech-powered engagement and loyalty platform, today released new behavioral data showing

Read More

Influenza Pipeline Insights 2026: Novel Mechanisms, Promising Candidates, and Competitive Landscape by DelveInsight | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Cidara

(Albany, New York) – November 10, 2026: As per DelveInsight’s assessment, globally, Influenza pipeline constitutes 120+ key companies continuously working towards developing 120+ Influenza treatment therapies, analysis of Clinical Trials,

Read More

Atrial Fibrillation Clinical Trials Update 2026: Phase-Wise Pipeline Status, Drug Profiles, and Key Developers by DelveInsight | Bayer, Johnson and Johnson, Bristol Myers Squibb, Daiichi Sankyo,Pfizer

(Albany, New York) – November 10, 2026: As per DelveInsight’s assessment, globally, Atrial Fibrillation pipeline constitutes 12+ key companies continuously working towards developing 15+ Atrial Fibrillation treatment therapies, analysis of

Read More

Huntington’s Disease Pipeline 2026: Who Is Leading the Race? Top Companies and Emerging Therapies to Watch by DelveInsight | Spark therapeutics, Chong Kun Dang Pharma, Neuvivo, UniQure Biopharma

(Albany, New York) – November 10, 2026: As per DelveInsight’s assessment, globally, Huntington’s Disease pipeline constitutes 20+ key companies continuously working towards developing 20+ Huntington’s Disease treatment therapies, analysis of

Read More

Soft Tissue Sarcoma Pipeline Landscape 2026: Late-Stage Candidates, MOA Trends, and ROA by DelveInsight | OncoTherapy Science, Foghorn Therapeutics, C4 Therapeutics, Lyvgen Biopharma Holdings

(Albany, New York) – November 10, 2026: As per DelveInsight’s assessment, globally, Soft Tissue Sarcoma pipeline constitutes 70+ key companies continuously working towards developing 75+ Soft Tissue Sarcoma treatment therapies,

Read More

Respiratory Syncytial Virus Market Anticipated to Witness Remarkable Growth by 2034, Says Latest Industry Analysis | GSK, MedImmune, ReViral, Pfizer, Sanofi, BioComo, IMV, Shionogi, Aridis Pharma

The Key Respiratory Syncytial Virus Companies in the market include – GSK, MedImmune, ReViral, Pfizer, Sanofi, BioComo, IMV, Shionogi, Aridis Pharmaceuticals, ADMA Biologics, Enanta Pharmaceuticals, Merck Sharp & Dohme, Janssen

Read More

Dynamic Industry Brings Mechanical Solar Panel Recycling to TechCrunch Disrupt as U.S. Waste Challenge Grows

NAMWON, South Korea – November 10, 2026 – Dynamic Industry presented its mechanical solar panel recycling technology at TechCrunch Disrupt 2026 in San Francisco, addressing a growing challenge for the

Read More

Age-related Macular Degeneration Clinical Trial Pipeline Expands as 90+ Companies Race to Redefine AMD Treatment Landscape | DelveInsight

The Age-related Macular Degeneration clinical trial analysis report delivers important insights into ongoing research on 100+ pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) November 10, 2026

Read More

Max Elofson Outlines Vision for Future Technology, Electric Mobility, and Design Through KMON and YR2M

Max Elofson, Founder of KMON and YR2M™ Drink Tech. Entrepreneur’s ventures explore gesture-controlled EVs, artificial intelligence, aerial mobility, and innovative beverage design. Los Angeles, CA – November 10, 2026 – Entrepreneur

Read More